- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Video
Telemedicine can help practices thrive during the COVID-19 crisis
Author(s):
Jules Lipoff, M.D., dermatologist and assistant professor of clinical dermatology, Penn Medicine, discusses telemedicine in the era of COVID-19.
In this brief interview, Jules Lipoff, M.D., dermatologist and assistant professor of clinical dermatology, Penn Medicine, highlights some of recent changes to the Centers for Medicare & Medicaid Services telehealth coverage policy. He also offers advice to colleagues implementing changes to their practice during the COVID-19 crisis, and discusses how this pandemic may give providers the chance to prove the efficacy of telemedicine for future practice.
For more guidance, please visit American Academy of Dermatology Teledermatology Toolkit and the coronavirus resources listed on the AAD website.
